Health Canada approves use of Dolphin Vagal Nerve Stimulator
The device is intended to treat symptoms like shortness of breath, cough, fatigue, joint and muscle pain, headaches,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 May 22
The device is intended to treat symptoms like shortness of breath, cough, fatigue, joint and muscle pain, headaches,…
04 May 22
KardiaComplete is an enterprise solution for employers, health insurance plans and health systems to improve heart health and…
04 May 22
Company ushers in a new era of transparency and efficiency by bringing to market the most diverse AI…
04 May 22
Physicians at Atlantic Health use Aidoc’s AI solutions to triage patient CT scans and receive alerts notifying them…
03 May 22
With the approval, Monarch platform becomes the first and only multi-speciality, flexible robotically assisted system designed for use…
02 May 22
In the study, 89% of patients treated with the company’s TactiCath SE for persistent AFib experienced no symptoms…
02 May 22
The double-blind, randomised, controlled Safe and Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D) clinical trial is expected to enrol…
02 May 22
The Endoluxe EVS is the perfect camera system for all endoscopic procedures that utilize industry standard rigid and…
02 May 22
Xcardia Innovation Ltd. is a private medical device company developing innovative cardiovascular technologies
02 May 22
Labs Across Canada Can Now Gain Speed, Cost-Efficient Scalability, and Consistency in a Hands-Free Swab Processing Workflow